Healthcare provider profile · identity verified

John Patrick Doty, MD

Family Practice · SAYRE, PA · NPI 1164497004

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	620	189
Lisinopril	Lisinopril	433	135
Levothyroxine Sodium	Levothyroxine Sodium	330	98
Omeprazole	Omeprazole	313	95
Amlodipine Besylate	Amlodipine Besylate	269	87
Metformin Hcl	Metformin Hcl	248	71
Metoprolol Succinate	Metoprolol Succinate	220	77
Tamsulosin Hcl	Tamsulosin Hcl	207	61
Citalopram Hbr	Citalopram Hydrobromide	199	60
Eliquis	Apixaban	199	44
Gabapentin	Gabapentin	199	62
Hydrochlorothiazide	Hydrochlorothiazide	196	68
Naproxen	Naproxen	170	71
Pantoprazole Sodium	Pantoprazole Sodium	170	58
Albuterol Sulfate Hfa	Albuterol Sulfate	168	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	165	22
Losartan Potassium	Losartan Potassium	160	54
Metoprolol Tartrate	Metoprolol Tartrate	159	45
Simvastatin	Simvastatin	156	51
Lorazepam	Lorazepam	152	35
Glimepiride	Glimepiride	151	43
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	148	26
Allopurinol	Allopurinol	144	39
Famotidine	Famotidine	143	46
Rosuvastatin Calcium	Rosuvastatin Calcium	117	41
Furosemide	Furosemide	110	37
Oxycodone Hcl	Oxycodone Hcl	109	24
Spironolactone	Spironolactone	98	37
Sertraline Hcl	Sertraline Hcl	97	23
Atenolol	Atenolol	96	29
Fluticasone Propionate	Fluticasone Propionate	96	37
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	94	29
Montelukast Sodium	Montelukast Sodium	94	28
Tramadol Hcl	Tramadol Hcl	94	29
Duloxetine Hcl	Duloxetine Hcl	91	21
Jardiance	Empagliflozin	86	17
Pregabalin	Pregabalin	81	15
Carvedilol	Carvedilol	74	19
Januvia	Sitagliptin Phosphate	74	13
Prednisone	Prednisone	70	35
Ezetimibe	Ezetimibe	64	17
Fluoxetine Hcl	Fluoxetine Hcl	61	21
Trazodone Hcl	Trazodone Hcl	61	17
Alprazolam	Alprazolam	59	13
Azithromycin	Azithromycin	59	52
Venlafaxine Hcl Er	Venlafaxine Hcl	56	16
Warfarin Sodium	Warfarin Sodium	56	20
Amitriptyline Hcl	Amitriptyline Hcl	55	15
Fentanyl	Fentanyl	55	suppressed
Ventolin Hfa	Albuterol Sulfate	54	15
Triamcinolone Acetonide	Triamcinolone Acetonide	52	29
Mirtazapine	Mirtazapine	48	20
Pioglitazone Hcl	Pioglitazone Hcl	47	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	11
Clopidogrel	Clopidogrel Bisulfate	45	16
Meclizine Hcl	Meclizine Hcl	45	13
Ozempic	Semaglutide	43	14
Finasteride	Finasteride	42	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Clonazepam	Clonazepam	41	12
Meloxicam	Meloxicam	41	17
Lantus	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	11
Ramipril	Ramipril	39	11
Zolpidem Tartrate	Zolpidem Tartrate	39	11
Potassium Chloride	Potassium Chloride	38	18
Alendronate Sodium	Alendronate Sodium	37	17
Synthroid	Levothyroxine Sodium	36	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	13
Fenofibrate	Fenofibrate	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	14
Topiramate	Topiramate	34	11
Glipizide Er	Glipizide	33	12
Mupirocin	Mupirocin	32	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	30
Buspirone Hcl	Buspirone Hcl	30	11
Glipizide	Glipizide	30	suppressed
Incruse Ellipta	Umeclidinium Bromide	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Valsartan	Valsartan	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Carisoprodol	Carisoprodol	28	suppressed
Torsemide	Torsemide	28	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Digoxin	Digoxin	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	12
Oxybutynin Chloride Er	Oxybutynin Chloride	26	11
Propranolol Hcl	Propranolol Hcl	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	11
Klor-Con M20	Potassium Chloride	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	23
Baclofen	Baclofen	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	15
Nystatin	Nystatin	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Bupropion Xl	Bupropion Hcl	20	11
Entresto	Sacubitril/Valsartan	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Levemir	Insulin Detemir	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Clotrimazole	Clotrimazole	18	12
Ibuprofen	Ibuprofen	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Levofloxacin	Levofloxacin	17	15
Metformin Hcl Er	Metformin Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Amoxicillin	Amoxicillin	16	12
Nitroglycerin	Nitroglycerin	16	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Nadolol	Nadolol	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Epinephrine	Epinephrine	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Diazepam	Diazepam	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error